A phase 1 study to assess the safety and immunogenicity of R21/Matrix-MTM administered in an escalating dose, multi-prime vaccination schedule in healthy adults (VAC096)

Principal Investigator

Prof Adrian Hill

Contact us

Email: vaccinetrials@ndm.ox.ac.uk

IRAS number

1008352